SETD2 and cancer: Thus, H3K36me3 deregulation drives oncogenesis and metastasis in cancers beyond RCC, suggesting that SETD2's tumor/metastasis suppressor function is conserved among different tissues and independent of mutations commonly linked to ccRCC like VHL and PBRM1 [10, 12].